These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 2014782)
1. Dysmegakaryopoiesis resembling acute megakaryoblastic leukemia in treated acute myeloid leukemia. Rosenthal NS; Farhi DC Am J Clin Pathol; 1991 Apr; 95(4):556-60. PubMed ID: 2014782 [TBL] [Abstract][Full Text] [Related]
2. A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager. Olatunji PO; Ojo OT; Bello FO; Bakare BY; Olatunji AO Malawi Med J; 2018 Dec; 30(4):298-301. PubMed ID: 31798811 [TBL] [Abstract][Full Text] [Related]
3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
4. The use of the anti-factor VIII method on trephine biopsies of the bone marrow for the identification of immature and atypical megakaryocytes in myeloproliferative diseases and allied disorders. A morphometric study. Thiele J; Krech R; Wienhold S; Simon KG; Zankovich R; Fischer R Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 54(2):89-97. PubMed ID: 2892311 [TBL] [Abstract][Full Text] [Related]
5. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group. Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG; Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158 [TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis. Imbert M; Nguyen D; Sultan C Leuk Res; 1992; 16(1):51-4. PubMed ID: 1732672 [TBL] [Abstract][Full Text] [Related]
8. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies]. Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999 [TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis. Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053 [TBL] [Abstract][Full Text] [Related]
10. p-Iodophenol-enhanced luminol chemiluminescent assay applied to discrimination between acute lymphoblastic and minimally differentiated acute myeloid (FAB-M0) or acute megakaryoblastic (FAB-M7) leukemias. da Costa M; Ximenes VF; Brunetti IL; Falcão RP; da Fonseca LM Hematol J; 2004; 5(6):496-9. PubMed ID: 15570291 [TBL] [Abstract][Full Text] [Related]
11. Erythroblastic and/or megakaryocytic dysplasia in de novo acute myeloid leukemias M0-M5 show relation to myelodysplastic syndromes and delimit two main categories. Lemez P; Gáliková J; Haas T Leuk Res; 2000 Mar; 24(3):207-15. PubMed ID: 10739003 [TBL] [Abstract][Full Text] [Related]
12. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia"). Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219 [TBL] [Abstract][Full Text] [Related]
13. [Poor response in patients with de novo acute myeloid leukemia and erythroblastic or megakaryocytic dysplasia to treatment with standard doses of cytosine arabinoside and daunorubicin]. Lemez P; Gáliková J; Haas T Vnitr Lek; 1999 Jun; 45(6):342-6. PubMed ID: 11045169 [TBL] [Abstract][Full Text] [Related]
14. Immunophenotyping of AML and MDS and detection of residual disease. Sanz MA; Sempere A Baillieres Clin Haematol; 1996 Mar; 9(1):35-55. PubMed ID: 8730550 [TBL] [Abstract][Full Text] [Related]
15. [Evolution to megakaryoblastic leukemia observed in myelodysplastic syndrome with erythrolekemia-like features]. Takai K; Sanada M; Shibuya H Rinsho Ketsueki; 1992 Aug; 33(8):1071-6. PubMed ID: 1404864 [TBL] [Abstract][Full Text] [Related]
16. CD34+ megakaryoblastic leukaemic cells are CD38-, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7? Helleberg C; Knudsen H; Hansen PB; Nikolajsen K; Kjaersgaard E; Ralfkiaer E; Johnsen HE Leukemia; 1997 Jun; 11(6):830-4. PubMed ID: 9177436 [TBL] [Abstract][Full Text] [Related]
17. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts. Langebrake C; Creutzig U; Reinhardt D Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category. Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284 [TBL] [Abstract][Full Text] [Related]
19. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia. Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH; Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580 [TBL] [Abstract][Full Text] [Related]
20. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome. Zipursky A; Christensen H; De Harven E Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]